Ketorolac use after oocyte retrieval: doing our part to combat the opioid crisis

Reflections
Published
Go to the profile of Fertility and Sterility
Fertility and Sterility
Editorial Office, American Society for Reproductive Medicine
Ketorolac use after oocyte retrieval: doing our part to combat the opioid crisis
Like

Related Content

F&S Reports
F&S Reports F&S Reports

Ketorolac use after oocyte retrieval: doing our part to combat the opioid crisis

The opioid epidemic claims nearly 50,000 lives per year and is associated with an annual economic cost of more than $80 billion in the United States alone (1). Surgery represents a critical time when both opioid-tolerant and opioid-naïve patients are exposed to narcotics, risking opioid-related adve…

VOLUME 2, ISSUE 2, P142-143, JUNE 01, 2021

Author:

Jessica R. Walter, M.D.

Abstract:

Reflections on "Routine ketorolac at oocyte retrieval decreases post-operative narcotic use by more than 50%" by Seidler et al.

Read the full text here. 

Go to the profile of Fertility and Sterility
Fertility and Sterility
Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. 

Please sign in or register for FREE

Your Fertility and Sterility Dialog login information is not the same as your ASRM or EES credentials. Users must create a separate account to comment or interact on the Dialog.

Sign In Register

Recommended Content